The seasonality of rhinovirus infections and its implications for clinical recognition

Clinical Therapeutics

Volumn 24, Issue 12, 2002, Pages 1987-1997

  Monto, Arnold S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Acute viral respiratory infection; Rhinovirus

Indexed keywords

BIOAVAILABILITY; CONTROLLED STUDY; GEOGRAPHY; HUMAN; INFLUENZA VIRUS; MEDICAL RESEARCH; MOLECULAR RECOGNITION; PARAINFLUENZA VIRUS; RESPIRATORY TRACT INFECTION; REVIEW; SEASONAL VARIATION; VIRUS TRANSMISSION;

EID: 0036926706     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(02)80093-5     Document Type: Review

References (37)

1. Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey, 1996. National Center for Health Statistics. Vital Health Stat. 1999;10.
2. Van Volkinburgh VA, Frost WH. Acute minor respiratory diseases prevailing in a group of families residing in Baltimore, Maryland, 1928-1930: Prevalence, distribution and clinical description of observed cases. Am J Hyg. 1933;17:122-153.
3. Lidwell OM, Sommerville T. Observations on the incidence and distribution of the common cold in a rural community during 1948 and 1949. J Hyg (Lond). 1951;49:365-381.
4. Badger GF, Dingle JH, Feller AE, et al. A study of illness in a group of Cleveland families. II. Incidence of the common respiratory diseases. Am J Hyg. 1953;58:31-40.
5. Gwaltney JM Jr, Jordan WS Jr. Rhinovirus and respiratory disease. Bacteriol Rev. 1964;28:409-422.
6. Monto AS, Johnson KM. A community study of respiratory infections in the tropics. II. The spread of six rhinovirus isolates within the community. Am J Epidemiol. 1968;88:55-68.
7. Ketler A, Hall CE, Fox JP, et al. The Virus Watch program: A continuing surveillance of viral infections in metropolitan New York families. 8. Am J Epidemiol. 1969;90:244-254.
8. Monto AS, Cavallaro JJ. The Tecumseh Study of Respiratory Illness. IV. Prevalence of rhinovirus serotypes, 1966-1969. Am J Epidemiol. 1972;96:352-360.
9. Johnston SL, Sanderson G, Pattemore PK, et al. Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol. 1993;31:111-117.
10. Hyypia T, Puhakka T, Ruuskanen O, et al. Molecular diagnosis of human rhinovirus infections: Comparison with virus isolation. J Clin Microbiol. 1998;36:2081-2083.
11. Rotbart HA. Antiviral therapy for enteroviruses and rhinoviruses. Antivir Chem Chemother. 2000;11:261-271.
12. Hayden FG, Coats T, Kim K, et al. Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: Efficacy and tolerability in phase II clinical trials. Antivir Ther. 2002;7:53-65.
13. Hayden FG, Kin M, Villano SA, for the Pleconaril Respiratory Infection Study Group. Pleconaril treatment provides early reduction of symptom severity in viral respiratory infection due to picornaviruses. In: Program and abstracts of the 39th Annual Meeting of the Infectious Diseases Society of America; October 25-28, 2001; San Francisco, Calif.
14. Monto AS, Bryan ER, Ohmit S. Rhinovirus infections in Tecumseh, Michigan: Frequency of illness and number of serotypes. J Infect Dis. 1987;156:43-49.
15. Pitkaranta A, Virolainen A, Jero J, et al. Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction. Pediatrics. 1998;102:291-295.
16. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993;307:982-986.
17. Nicholson KG, Kent J, Hammersley V, Cancio E. Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: Prospective cohort study. BMJ. 1996;313:1119-1123.
18. Monto AS, Ross H. Acute respiratory illness in the community: Effect of family composition, smoking, and chronic symptoms. Br J Prev Soc Med. 1977;31:101-108.
19. Makela MJ, Puhakka T, Ruuskanen O, et al. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol. 1998;36:539-542.
20. Arruda E, Pitkaranta A, Witek TJ Jr, et al. Frequency and natural history of rhinovirus infections in adults during autumn. J Clin Microbiol. 1997;35:2864-2868.
21. Monto AS, Cavallaro JJ. The Tecumseh Study of Respiratory Illness. II. Patterns of occurrence of infection with respiratory pathogens, 1965-1969. Am J Epidemiol. 1971;94:280-289.
22. Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect. 1993;110:145-160.
23. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ. 1995;310:1225-1229.
24. Monto AS, Koopman JS, Longini IM Jr. Tecumseh Study of Illness. XIII. Influenza infection and disease, 1976-1981. Am J Epidemiol. 1985;121:811-822.
25. Syndenstricker E. A study of illness in a general population group. Hagerstown Morbidity Studies No. I: The method and general results. Public Health Rep. 1926;41:2069-2088.
26. Frost WH, Gover M. The incidence and time distribution of common colds in several groups kept under continuous observation. Public Health Rep. 1932;47:1815-1841.
27. Dingle JH, Badger GF, Jordan WS Jr. Illness in the Home: A Study of 25,000 Illnesses in a Group of Cleveland Families. Cleveland, Ohio: Western Reserve University Press; 1964.
28. Monto AS, Ullman BM. Acute respiratory illness in an American community. The Tecumseh Study. JAMA. 1974;227:164-169.
29. Larsen HE, Reed SE, Tyrell DAJ. Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol. 1980;5:221-229.
30. Gwaltney JM Jr, Hendley JO, Simon G, Jordan WS Jr. Rhinovirus infections in an industrial population. I. The occurrence of illness. N Engl J Med. 1966;275:1261-1268.
31. Fox JP, Cooney MK, Hall CE. The Seattle Virus Watch. V. Epidemiologic observations of rhinovirus infections, 1965-1969, in families with young children. Am J Epidemiol. 1975;101:122-143.
32. Monto AS, Shope TC, Schwartz SA, Albrecht JK. Intranasal interferon-α2b for seasonal prophylaxis of respiratory infection. J Infect Dis. 1986;154:128-133.
33. Monto AS, Albrecht JK, Schwartz SA. Demonstration of dose-response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon. Antimicrob Agents Chemother. 1988;32:47-50.
34. Monto AS, Schwartz SA, Albrecht JK. Ineffectiveness of postexposure prophylaxis of rhinovirus infection with low-dose intranasal alpha 2b interferon in families. Antimicrob Agents Chemother. 1989;33:387-390.
35. Gwaltney JM Jr, Hendley JO, Simon G, Jordan WS Jr. Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response. JAMA. 1967;202:494-500.
36. Monto AS, Gravenstein S, Elliott M, et al. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160:3243-3247.
37. Boivin G, Hardy I, Tellier G, Maziade J. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis. 2000;31:1166-1169.